Johnson & Johnson Q2 profit up 9%

Johnson & Johnson also announced the Q2 earnings. The profit added 9% to US$1.48 bln and per share fell short of market expectation and stood at 48 US cents while turnover climbed up 8.8% to hit US$8.3 bln. Pfizer gained 71 US cents, or 1.87% to close at US$38.58 and Johnson & Johnson won US$1.18, or 2.2% to end at US$54.91.

Related stock : (NIL)